Central Texas TX

Nanoscope Therapeutics Announces FDA Clearance of IND for MCO-010 Gene Therapy in Stargardt Macular Degeneration Patients

Brenham Banner Press

Jan 25, 2022

BEDFORD, Texas, Jan. 25, 2022 /PRNewswire/ -- Nanoscope Therapeutics Inc., a clinical-stage biotechnology company developing gene therapies for retinal degenerative diseases, today…

Read the full story at Brenham Banner Press

Related places

Brenham

Nanoscope Therapeutics Announces FDA Clearance of IND for MCO-010 Gene Therapy in Stargardt Macular Degeneration Patients

Related places

More from Central Texas

Hilltoppers Pick Up The Pace In Final Race Before Conference Meet

Bobcats Set to Close Fall Slate at Qubein Cup

Business Briefs

Bell County candidates debate taxes, education and growth at LULAC forum

Taxpayers pay the price when Texas education department takes over school districts

Does the planned execution of Nidal Hasan carry potential risks?

More than a blemish: Temple dermatologist explains basal cell carcinoma and why early detection matters

House District 55 candidates offer contrasting visions on education, veteran tax relief